Differential diagnosis between lymphoma-associated malignant pleural effusion and tuberculous pleural effusion.
Malignant pleural effusion (MPE)
adenosine deaminase (ADA)
lactate dehydrogenase (LDH)
lymphoma
tuberculous pleural effusion (TPE)
Journal
Annals of translational medicine
ISSN: 2305-5839
Titre abrégé: Ann Transl Med
Pays: China
ID NLM: 101617978
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
entrez:
27
9
2019
pubmed:
27
9
2019
medline:
27
9
2019
Statut:
ppublish
Résumé
Lymphoma-associated malignant pleural effusions (L-MPE) can mimic tuberculous pleural effusion (TPE) characterized by lymphocytic exudate with high adenosine deaminase (ADA) levels. Furthermore, the low cytological yield of L-MPE makes differentiation between L-MPE and TPE more challenging. However, there are few data regarding differential diagnosis of L-MPE and TPE. All consecutive patients diagnosed with L-MPE or TPE between January 2011 and December 2016 were retrospectively recruited using the Electronic Medical Record database. Clinical symptoms and laboratory and pleural fluid data [including serum lactate dehydrogenase (LDH), C-reactive protein, and pleural fluid ADA levels] were compared between L-MPE and TPE. Useful variables in the differential diagnosis of L-MPE and TPE were evaluated by multivariate logistic regression analysis. Seventeen patients with L-MPE and 216 patients with TPE were included in this study. In the multivariate analysis, fever was negatively associated with L-MPE [odds ratio (OR): 0.175, 95% confidence interval (CI): 0.033-0.941, P=0.042], while serum LDH levels were positively associated with L-MPE (OR: 1.005, 95% CI: 1.003-1.007, P<0.001). Serum LDH >460 U/L provided a sensitivity of 76% and a specificity of 81% to distinguish L-MPE and TPE. In contrast, serum C-reactive protein and pleural fluid ADA levels were not significantly different between the groups. Patients with L-MPE and TPE present very similar clinical, laboratory, and pleural fluid characteristics. Fever and serum LDH levels may be helpful in guiding the differential diagnosis of L-MPE and TPE. Lymphoma should be kept in mind in the differential diagnosis in patients with lymphocytic pleural effusion and high ADA levels.
Sections du résumé
BACKGROUND
BACKGROUND
Lymphoma-associated malignant pleural effusions (L-MPE) can mimic tuberculous pleural effusion (TPE) characterized by lymphocytic exudate with high adenosine deaminase (ADA) levels. Furthermore, the low cytological yield of L-MPE makes differentiation between L-MPE and TPE more challenging. However, there are few data regarding differential diagnosis of L-MPE and TPE.
METHODS
METHODS
All consecutive patients diagnosed with L-MPE or TPE between January 2011 and December 2016 were retrospectively recruited using the Electronic Medical Record database. Clinical symptoms and laboratory and pleural fluid data [including serum lactate dehydrogenase (LDH), C-reactive protein, and pleural fluid ADA levels] were compared between L-MPE and TPE. Useful variables in the differential diagnosis of L-MPE and TPE were evaluated by multivariate logistic regression analysis.
RESULTS
RESULTS
Seventeen patients with L-MPE and 216 patients with TPE were included in this study. In the multivariate analysis, fever was negatively associated with L-MPE [odds ratio (OR): 0.175, 95% confidence interval (CI): 0.033-0.941, P=0.042], while serum LDH levels were positively associated with L-MPE (OR: 1.005, 95% CI: 1.003-1.007, P<0.001). Serum LDH >460 U/L provided a sensitivity of 76% and a specificity of 81% to distinguish L-MPE and TPE. In contrast, serum C-reactive protein and pleural fluid ADA levels were not significantly different between the groups.
CONCLUSIONS
CONCLUSIONS
Patients with L-MPE and TPE present very similar clinical, laboratory, and pleural fluid characteristics. Fever and serum LDH levels may be helpful in guiding the differential diagnosis of L-MPE and TPE. Lymphoma should be kept in mind in the differential diagnosis in patients with lymphocytic pleural effusion and high ADA levels.
Identifiants
pubmed: 31555687
doi: 10.21037/atm.2019.07.17
pii: atm-07-16-373
pmc: PMC6736794
doi:
Types de publication
Journal Article
Langues
eng
Pagination
373Déclaration de conflit d'intérêts
Conflicts of Interest: The authors have no conflicts of interest to declare.
Références
Am J Respir Crit Care Med. 2000 Nov;162(5):1987-2001
pubmed: 11069845
Science. 2001 Apr 20;292(5516):504-7
pubmed: 11283355
Cancer Res. 1964 Apr;24:389-99
pubmed: 14147812
Chest. 2004 Jan;125(1):156-9
pubmed: 14718435
Respirology. 2004 Mar;9(1):66-9
pubmed: 14982604
Chest. 2004 Apr;125(4):1546-55
pubmed: 15078773
Nat Rev Cancer. 2004 Nov;4(11):891-9
pubmed: 15516961
Mayo Clin Proc. 2005 Jul;80(7):867-70
pubmed: 16007891
Diagn Cytopathol. 2006 May;34(5):335-47
pubmed: 16604559
Clin Infect Dis. 2006 Jun 1;42(11):1592-5
pubmed: 16652317
Respir Med. 2008 May;102(5):744-54
pubmed: 18222681
Respirology. 2010 Apr;15(3):451-8
pubmed: 20345583
Eur J Intern Med. 2010 Oct;21(5):419-23
pubmed: 20816597
J Bras Pneumol. 2012 Mar-Apr;38(2):181-7
pubmed: 22576425
S Afr Med J. 2012 Nov 02;103(1):32-3
pubmed: 23237121
Dis Mon. 2013 Feb;59(2):29-57
pubmed: 23374395
Acta Haematol. 2013;130(4):305-11
pubmed: 24008775
Acad Radiol. 2014 Jan;21(1):11-20
pubmed: 24331260
QJM. 2014 Nov;107(11):887-93
pubmed: 24854180
Br J Cancer. 2014 Jul 8;111(1):55-60
pubmed: 24874478
Haematologica. 2014 Dec;99(12):1817-25
pubmed: 25216682
Am J Clin Pathol. 2015 May;143(5):707-15
pubmed: 25873505
Lancet. 2016 Mar 19;387(10024):1211-26
pubmed: 26377143
Lung. 2016 Feb;194(1):147-53
pubmed: 26678281
Infection. 2017 Feb;45(1):59-65
pubmed: 27488820
Acta Cytol. 2016;60(4):354-364
pubmed: 27578145
Tuberc Respir Dis (Seoul). 2017 Jan;80(1):77-82
pubmed: 28119750
Lancet. 2017 Jul 15;390(10091):298-310
pubmed: 28153383
J Glob Oncol. 2016 Jan 13;2(1):26-29
pubmed: 28717679
J Infect. 2017 Dec;75(6):581-583
pubmed: 28804026
Am J Med Sci. 2017 Aug;354(2):125-130
pubmed: 28864369
Cancer. 1985 Aug 15;56(4):905-9
pubmed: 4016683
Acta Haematol. 1984;72(4):231-8
pubmed: 6438991
Leuk Res. 1981;5(3):215-22
pubmed: 6973675
Leuk Lymphoma. 1998 Oct;31(3-4):351-7
pubmed: 9869199
Br J Haematol. 1976 Dec;34(4):631-8
pubmed: 990193